Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.

All News

National Harbor Medical Pavilion Stands atop Trend  as
Healthcare & PharmaceuticalCompany Update

National Harbor Medical Pavilion Stands atop Trend  as "Live, Work, Play, Healthcare" Demand Surges across U.S.

August 12, 2025 2:50 PM

A rare leasing opportunity has opened in one of the Washington, D.C. region's most dynamic suburban destinations, as Medical Pavillion I & II at National Harbor announces availability at a Class-A medical office building strategically located within a bustling live, work, play campus - now redefined as "live, work, play, healthcare."As health systems and specialty providers expand closer to where patients live and work, this medical office...

Read more
Native Path Collagen Reviews: Don't Buy Until You've Read This
Healthcare & PharmaceuticalCompany Update

Native Path Collagen Reviews: Don't Buy Until You've Read This

August 12, 2025 2:50 PM

Are you tired of watching your skin lose its youthful glow, feeling joint stiffness every morning, or noticing your hair thinning with each passing year? What if we told you there's a single, tasteless powder that could reverse these signs of aging and restore your vitality? Meet Native Path Grass-Fed Collagen - the revolutionary supplement that's sold out three times and helped thousands reclaim their youth! This isn't just another collagen...

Read more
Black Book: Cloud Transformation Now Core to Provider Growth Strategies in $275B Market Expansion
Healthcare & PharmaceuticalProduct Announcements

Black Book: Cloud Transformation Now Core to Provider Growth Strategies in $275B Market Expansion

August 12, 2025 2:30 PM

Cloud transformation has emerged as a defining growth lever for healthcare organizations, reshaping technology roadmaps, operating models, and capital allocation strategies. Black Book Research's eight-month study, spanning 890 provider and payer organizations, finds that 78% of U.S. hospitals, health systems, and physician groups have approved significant cloud investments to be completed by mid-2026.The findings point to a sector-wide...

Read more
New Study Reveals Serious Pitfalls of Focused Professional Practice Evaluations (FPPE) and Anonymous Reporting in Medicine
Healthcare & PharmaceuticalCompany Update

New Study Reveals Serious Pitfalls of Focused Professional Practice Evaluations (FPPE) and Anonymous Reporting in Medicine

August 12, 2025 2:00 PM

A new study, Focused Professional Practice Evaluation and the Weaponization of Anonymous Reporting: Erosion of Care and Fairness, has raised significant concerns regarding potential negative consequences from current healthcare oversight systems and anonymous reporting. FPPE systems and anonymous reporting in healthcare, particularly in the field of surgery. The research, led by Dominic Moore and colleagues from Avicenna Technical University...

Read more
Veterinary Referral Center of Central Oregon Expands Life-Saving Treatment Options With Extracorporeal Therapies
Healthcare & PharmaceuticalCompany Update

Veterinary Referral Center of Central Oregon Expands Life-Saving Treatment Options With Extracorporeal Therapies

August 12, 2025 12:30 PM

The Veterinary Referral Center of Central Oregon (VRCCO) is proud to announce the addition of advanced Extracorporeal Therapies, including Hemodialysis, Therapeutic Plasma Exchange, and Hemoperfusion, to its suite of specialized veterinary services. VRCCO is honored to be among the few facilities in the US to offer these cutting-edge treatments that provide new hope for pets suffering from acute kidney injuries, chronic kidney disease,...

Read more
VSee Health Appeals NASDAQ Staff Delisting Notice
Healthcare & PharmaceuticalCompany Update

VSee Health Appeals NASDAQ Staff Delisting Notice

August 12, 2025 12:15 PM

VSee Health, Inc. (Nasdaq:VSEE) (the "Company"), a leader in telehealth solutions, today announced that it has requested a hearing before a Nasdaq Listing Qualifications Panel to appeal an earlier Staff Determination to delist the Company's common stock from the Nasdaq Capital Market.VSee Health received a letter from the Nasdaq Stock Market ("Nasdaq") on August 5th, 2025 indicating that the Company did not comply with the NASDAQ's filing...

Read more
Nerve Calm: The Natural Supplement NerveCalm to Soothe Nerve Pain and Boost Your Energy
Healthcare & PharmaceuticalAdvertorial

Nerve Calm: The Natural Supplement NerveCalm to Soothe Nerve Pain and Boost Your Energy

August 12, 2025 12:05 PM

Hurry up! A common term that you would come across on several occasions in this busy world. Don't you feel that hurrying up on certain things can reduce your efficiency? Yes, it has to have an impact on the nervous system of your body, and that is when you fail to give your best. To give your best, Nerve Calm is a must for calming down your nerves and keeping yourself concentrated and focused.How do you calm down your nerves when the expectation...

Read more
Discover How Aletheia Strengthens Your Hospital's HR
Healthcare & PharmaceuticalCompany Update

Discover How Aletheia Strengthens Your Hospital's HR

August 12, 2025 11:00 AM

Human Resources Departments at rural hospitals carry a heavy load. Not only do they have to manage employee relations and administer benefits, they must oversee complex tasks, like complying with multiple state and federal regulations, which can sometimes change. Workforce challenges like recruiting and retention can be challenging, too-not just attracting nurses and other staff, but identifying what it is that makes employees want to stay,...

Read more
MDaudit Finalizes Acquisition of Streamline Health
Healthcare & PharmaceuticalMergers and Acquisitions

MDaudit Finalizes Acquisition of Streamline Health

August 12, 2025 9:35 AM

MDaudit, an award-winning cloud-based continuous risk monitoring platform for RCM that enables the nation's premier healthcare organizations to minimize billing risks and maximize revenues, has finalized its acquisition of Streamline Health Solutions, Inc., a leading provider of solutions that enable healthcare providers to improve financial performance. The addition of Streamline's pre-bill integrity solutions to its robust billing compliance...

Read more
Dr. Peter Talisse Joins Ankle & Foot Centers of America, Serving Peachtree City, Newnan, and Fayetteville
Healthcare & PharmaceuticalCompany Update

Dr. Peter Talisse Joins Ankle & Foot Centers of America, Serving Peachtree City, Newnan, and Fayetteville

August 12, 2025 9:01 AM

Ankle & Foot Centers of America is proud to welcome Dr. Peter Talisse, a board-qualified foot and ankle surgeon, to its physician team. Dr. Talisse will serve patients in the practice's Peachtree City, Newnan, and Fayetteville offices, expanding access to advanced podiatric care in the South Metro Atlanta region.Dr. Talisse grew up in Peachtree City and is excited to return to his hometown to care for the community that helped shape his medical...

Read more
Arintra Raises $21M Series A to Expand Beyond Autonomous Medical Coding and Build the Future of Healthcare Revenue Assurance
Healthcare & PharmaceuticalFinancing

Arintra Raises $21M Series A to Expand Beyond Autonomous Medical Coding and Build the Future of Healthcare Revenue Assurance

August 12, 2025 9:00 AM

Arintra, the leading GenAI-native autonomous medical coding platform for healthcare providers, today announced $21 million in Series A funding. The round was led by Peak XV Partners, with participation from Endeavor Health Ventures, Y Combinator, Counterpart Ventures, Spider Capital, Ten13, and other strategic investors. The investment will fuel Arintra's growth as it expands adoption across health systems and physician groups nationwide. The...

Read more
Jaguar Health to Hold Investor Webcast Thursday, August 14 at 8:30 AM Eastern Regarding Q2 2025 Financials & Corporate Updates
Healthcare & PharmaceuticalConference Call

Jaguar Health to Hold Investor Webcast Thursday, August 14 at 8:30 AM Eastern Regarding Q2 2025 Financials & Corporate Updates

August 12, 2025 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the company will conduct an investor webcast on Thursday, August 14, 2025, at 8:30 a.m. Eastern to review second-quarter 2025 financials and provide corporate updates.Participation Instructions for Jaguar Investor WebcastWhen: Thursday, August 14, 2025 at 8:30 AM Eastern TimeParticipant Registration & Access Link: Click HereParticipation Instructions for Jaguar's Virtual Presentation at the...

Read more
MIRA Pharmaceuticals' Second Ketamir-2 Manuscript Accepted for Peer-Reviewed Publication Demonstrating Superior Efficacy in Preclinical Neuropathic Pain Models Versus Ketamine, Gabapentin, or Pregabalin
Healthcare & PharmaceuticalCompany Update

MIRA Pharmaceuticals' Second Ketamir-2 Manuscript Accepted for Peer-Reviewed Publication Demonstrating Superior Efficacy in Preclinical Neuropathic Pain Models Versus Ketamine, Gabapentin, or Pregabalin

August 12, 2025 8:30 AM

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), a clinical-stage pharmaceutical company developing novel oral therapeutics for neurologic, neuropsychiatric, and metabolic disorders, today announced the acceptance of a second peer-reviewed manuscript describing its lead oral drug candidate, Ketamir-2, in Frontiers in Pharmacology.The newly accepted publication reports that Ketamir-2 outperformed ketamine, pregabalin, or...

Read more
Vheda Health Ranks No. 662 on the 2025 Inc. 5000 List of America’s Fastest-Growing Private Companies
Healthcare & PharmaceuticalAwards

Vheda Health Ranks No. 662 on the 2025 Inc. 5000 List of America’s Fastest-Growing Private Companies

August 12, 2025 8:00 AM

Inc., the leading media brand and playbook for the entrepreneurs and business leaders shaping our future, today announced that Vheda Health is No. 662 on the annual Inc. 5000 list, the most prestigious ranking of the fastest-growing private companies in America. The list provides a data-driven snapshot of the most successful companies within the economy's most dynamic segment-its independent, entrepreneurial businesses. Past honorees include...

Read more
enBio Appoints Ryan Kneeland as Vice President of Sales to Drive National Growth and Customer Value
Healthcare & PharmaceuticalCompany Update

enBio Appoints Ryan Kneeland as Vice President of Sales to Drive National Growth and Customer Value

August 12, 2025 8:00 AM

enBio Corp, a specialized healthcare services company known for delivering gold-standard service with unmatched value, is proud to announce the appointment of Ryan Kneeland as Vice President of Sales. In this role, Ryan will lead the company's national sales strategy across all five divisions, guiding enBio's next phase of strategic expansion while reinforcing its commitment to excellence, precision, and client success. With more than a decade...

Read more
Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on the VETIGEL(R) Hemostatic Product - The Future of Rapid Bleeding Control in Veterinary Medicine
Healthcare & PharmaceuticalCompany Update

Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on the VETIGEL(R) Hemostatic Product - The Future of Rapid Bleeding Control in Veterinary Medicine

August 12, 2025 6:30 AM

Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering advanced diagnostic and therapeutic solutions for equine and companion animals, is pleased to announce the next installment of its Fourth Friday at Four webinar series, scheduled for Friday, August 22, 2025, at 4:00 PM ET.This month's session will highlight VETIGEL® hemostatic gel, Zomedica's innovative, plant-based solution designed for rapid and...

Read more
Amphastar Pharmaceuticals Bolsters Proprietary Pipeline Through Exclusive Licensing Agreement with Nanjing Anji Biotechnology Co., Ltd.
Healthcare & PharmaceuticalCompany Update

Amphastar Pharmaceuticals Bolsters Proprietary Pipeline Through Exclusive Licensing Agreement with Nanjing Anji Biotechnology Co., Ltd.

August 12, 2025 6:00 AM

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar"), a biopharmaceutical company focused on developing, manufacturing, and marketing complex generic and proprietary injectable, inhalation, and intranasal products, today announced that it has entered into an exclusive license agreement ("Agreement") with Nanjing Anji Biotechnology Co., Ltd. ("Anji") for the development, manufacturing, use, and commercialization of three proprietary...

Read more
Markus Rohrwild Appointed New CEO of Gubra in a Planned Succession Process
Healthcare & PharmaceuticalRegulatory

Markus Rohrwild Appointed New CEO of Gubra in a Planned Succession Process

August 12, 2025 5:00 AM

Gubra (CPH:GUBRA)Following a planned succession process, the Board of Directors of Gubra has appointed Markus Rohrwild as the new CEO of the company effective September 8, 2025. Henrik Blou will step down after almost 10 years as CEO.Gubra Chair of the Board Monika Lessl said: " Henrik has done an outstanding job as CEO over the past almost 10 years, not least demonstrated by Gubra's significant revenue growth. He played a key role in the...

Read more
Invitation to the Presentation of Cantargia's H1 2025 Report
Healthcare & PharmaceuticalCompany Update

Invitation to the Presentation of Cantargia's H1 2025 Report

August 12, 2025 4:35 AM

Cantargia (Cantargia AB (publ); Nasdaq Stockholm:CANTA) will publish the company's interim report for the first six months of 2025 on Thursday, August 21, 2025, at 07:00 a.m. CEST.In conjunction to the report, Cantargia invites investors, analysts, and media to an audiocast with teleconference (in English) on August 21, at 3:00 p.m. CEST, where Cantargia's interim CEO Damian Marron, CBO Ton Berkien, and CFO Patrik Renblad, will present Cantargia...

Read more
President Trump Signals Openness to Medical Cannabis-MMJ BioPharma Files Emergency Motion to DEA Administrator Terry Cole
Healthcare & PharmaceuticalCompany Update

President Trump Signals Openness to Medical Cannabis-MMJ BioPharma Files Emergency Motion to DEA Administrator Terry Cole

August 11, 2025 6:30 PM

MMJ BioPharma Cultivation announced today it will file an emergency motion directly to newly confirmed DEA Administrator Terrance "Terry" Cole, seeking immediate action on the company's long delayed application to grow pharmaceutical grade cannabis for FDA approved clinical trials in Huntington's disease and Multiple Sclerosis. The move comes just hours after President Donald Trump addressed the nation on marijuana rescheduling,...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?